Rosemont Pharma appoints new CEO as business expands globally
UK based liquid medicines maker Rosemont Pharmaceuticals has appointed an American chief executive (CEO) as the business continues to expand into the USA, Canadian and European pharma market.
Alok Sonig joins the company from Chicago-based Baxter International (NYSE: BAX) where he was the executive vice-president and group president of pharmaceuticals with responsibility for global business. He takes over the role from the previous CEO Howard Taylor who retired earlier this year.
Mr Sonig has a 30-year history in generic medicine and biosimilars together with developing and expanding markets in the US, Canada, Europe and Japan. Previous roles include CEO at Lupin Pharmaceuticals and Dr Reddy’s Laboratories.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
More on this story...
Today's issue
Company Spotlight
More Features in Pharmaceutical
| Headless Content Management with Blaze